| 000 | 01575 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518003518.0 | ||
| 264 | 0 | _c20190311 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-018-4810-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhong, Brian | |
| 245 | 0 | 0 |
_aRigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2. _h[electronic resource] |
| 260 |
_bBMC cancer _cOct 2018 |
||
| 300 |
_a1007 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Staging _xmethods |
| 650 | 0 | 4 |
_aRenal Insufficiency _xchemically induced |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLawson, Benjamin O | |
| 700 | 1 | _aMa, Junjie | |
| 700 | 1 | _aMcGovern, Cheryl | |
| 700 | 1 | _aVan Atta, Joan K | |
| 700 | 1 | _aRay, Abhijit | |
| 700 | 1 | _aKhong, Hung T | |
| 773 | 0 |
_tBMC cancer _gvol. 18 _gno. 1 _gp. 1007 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-018-4810-y _zAvailable from publisher's website |
| 999 |
_c28960039 _d28960039 |
||